ABC | Volume 113, Nº5, Novembro 2019

Minieditorial Rodrigues Automonitorização com ou sem telemonitorização Arq Bras Cardiol. 2019; 113(5):976-978 1. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):1269-1324. 2. MalachiasMVB, Rodrigues CI Júnior, Muxfeldt E, Salles GF, MorenoH Júnior, Gus M. 7th Brazilian Guideline of Arterial Hypertension: Chapter 13 - Resistant Arterial Hypertension. Arq Bras Cardiol. 2016;107 (3Supl 3):75-8. 3. Brasil. Ministério da Saúde. VIGITEL – Vigilância de Fatores de Risco e Proteção paraDoenças Cr nicas por Inquérito Telef nico. [Internet]. [citado 09 out. 2019]; 2019. Disponível em: https://portalarquivos2.saude.gov.br/ images/pdf/2019/julho/25/vigitel-brasil-2018.pdf. 4. Merai R, Siegel C, Rakotz M, Basch P, Wright J, Wong B; et al. CDC Grand Rounds: A Public Health Approach to Detect and Control Hypertension (MMWR). Weekly. 2016;65(45):1261-4. 5. Muntner P, Shimbo CD, Carey RM, Charleston JB, Gaillard T, Misra S, et al. Measurement of blood pressure in humans: a scientific statement from the American Heart Association. Hypertension. 2019;73:e35–e66. 6. Nobre F, Mion Jr D, Gomes MAM, Barbosa ECD, Rodrigues CIS, Neves MFT, et al. 6ª Diretrizes de Monitorização Ambulatorial da Pressão Arterial e 4ª Diretrizes de Monitorização Residencial da Pressão Arterial. Arq Bras Cardiol. 2018;110(5 Supl 1):1-29. 7. Magid DJ, Green BB. Home blood pressure monitoring: take it to the bank. JAMA. 2013;310(1):40-1. 8. McManus RJ, Mant J, Franssen M, Nickless A, Schwartz C, Hodgkinson J, et al. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. Lancet. 2018;391(10124):949-59. 9. Hanley J, PinnockH, PatersonM, McKinstry B. Implementing telemonitoring in primary care: learning from a large qualitative dataset gathered during a series of studies. BMC Fam Pract. 2018;19(1):118. 10. Barroso WKS, Feitosa ADM, Barbosa ECD, Miranda RD, Brandão AA, Vitorino PVO, et al. Prevalence of Masked and White-Coat Hypertension in Pre-Hypertensive and Stage 1 Hypertensive patients with the use of TeleMRPA. Arq Bras Cardiol. 2019; 113(5):970-975. 11. Booth JN 3rd, Li J, Zhang L, Chen L, Muntner P, Egan B. Trends in Prehypertension and Hypertension Risk Factors in US Adults: 1999-2012. Hypertension. 2017;70(2):275-84. 12. Pellegrini D, Parati G. Communication technology for the management of hypertension: benefits and pitfalls. E-Journal Cardiol Practice. [Internet]. [citado 19 out. 2019]; 2019;17(9). Disponível em: https:// www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-17/ communication-technology-for-the-management-of-hypertension- benefits-and-pitfalls. 13. Kitt J, Fox R, Tucker KL, McManus RJ. New approaches in hypertension management: a review of current and developing technologies and their potential impact on hypertension care. Curr Hypertens Rep. 2019;21(6):44. 14. Woo SH, Choi YY, KimDJ, Bien F, Kim JJ. Tissue-informative mechanism for wearablenon-invasivecontinuousbloodpressuremonitoring.SciRep.2014 Oct 21;4:6618. Referências Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 978